Ignite Creation Date:
2024-05-06 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03111732
Status:
COMPLETED
Last Update Posted:
2021-12-03
First Post:
2017-04-12
Brief Title:
Pembrolizumab a Monoclonal Antibody Against PD-1 in Combination With Capecitabine and Oxaliplatin CAPOX in People With Advanced Biliary Tract Carcinoma BTC
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-14
Start Date Type:
ACTUAL
Primary Completion Date:
2020-07-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-04-12
First Submit QC Date:
April 12 2017
Study First Post Date:
2017-04-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-04-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-01
Last Update Post Date:
2021-12-03
Last Update Post Date Type:
ACTUAL